AU3325095A - Composition and method for protection against drug dependency - Google Patents

Composition and method for protection against drug dependency

Info

Publication number
AU3325095A
AU3325095A AU33250/95A AU3325095A AU3325095A AU 3325095 A AU3325095 A AU 3325095A AU 33250/95 A AU33250/95 A AU 33250/95A AU 3325095 A AU3325095 A AU 3325095A AU 3325095 A AU3325095 A AU 3325095A
Authority
AU
Australia
Prior art keywords
composition
protection against
against drug
drug dependency
dependency
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU33250/95A
Inventor
David Reed Helton
Mary Jeanne Kallman
James Allen Monn
Darryle Darwin Schoepp
Joseph Patrick Tizzano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/496,642 external-priority patent/US5661184A/en
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of AU3325095A publication Critical patent/AU3325095A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34Tobacco-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/46Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C229/50Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups and carboxyl groups bound to carbon atoms being part of the same condensed ring system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C62/00Compounds having carboxyl groups bound to carbon atoms of rings other than six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C62/30Unsaturated compounds
    • C07C62/38Unsaturated compounds containing keto groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/14All rings being cycloaliphatic
    • C07C2602/18All rings being cycloaliphatic the ring system containing six carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Addiction (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU33250/95A 1994-08-12 1995-08-14 Composition and method for protection against drug dependency Abandoned AU3325095A (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US28995794A 1994-08-12 1994-08-12
US289957 1994-08-12
US33734994A 1994-11-10 1994-11-10
US337349 1994-11-10
US08/496,642 US5661184A (en) 1994-08-12 1995-06-29 Psychiatric agents
US496642 1995-06-29
PCT/US1995/010317 WO1996004900A1 (en) 1994-08-12 1995-08-14 Composition and method for protection against drug dependency

Publications (1)

Publication Number Publication Date
AU3325095A true AU3325095A (en) 1996-03-07

Family

ID=27403948

Family Applications (1)

Application Number Title Priority Date Filing Date
AU33250/95A Abandoned AU3325095A (en) 1994-08-12 1995-08-14 Composition and method for protection against drug dependency

Country Status (5)

Country Link
EP (1) EP0776200A4 (en)
JP (1) JP3618104B2 (en)
AU (1) AU3325095A (en)
CA (1) CA2195779A1 (en)
WO (1) WO1996004900A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5688826A (en) * 1995-11-16 1997-11-18 Eli Lilly And Company Excitatory amino acid derivatives
NZ323205A (en) * 1995-11-16 1999-06-29 Lilly Co Eli Excitatory amino acid derivatives
GB9605429D0 (en) * 1995-11-16 1996-05-15 Lilly Co Eli Excitatory amino acid receptor antagonists
US5912248A (en) * 1995-11-16 1999-06-15 Eli Lilly And Company Excitatory amino acid receptor antagonists
WO1997017950A1 (en) * 1995-11-16 1997-05-22 Eli Lilly And Company Shoulder prosthesis
ZA969485B (en) * 1995-11-16 1998-05-12 Lilly Co Eli Excitatory amino acid receptor antagonists.
ZA983930B (en) * 1997-05-14 1999-11-08 Lilly Co Eli Excitatory amino acid receptor modulators.
JP4192331B2 (en) 1999-04-16 2008-12-10 住友化学株式会社 Process for producing optically active 2-oxobicyclo [3.1.0] hexane-6-carboxylic acid derivative
KR20200035035A (en) 2017-07-31 2020-04-01 노파르티스 아게 Use of mabogluant for reducing cocaine use or preventing recurrence of cocaine

Also Published As

Publication number Publication date
CA2195779A1 (en) 1996-02-22
JP3618104B2 (en) 2005-02-09
EP0776200A1 (en) 1997-06-04
WO1996004900A1 (en) 1996-02-22
JPH10504038A (en) 1998-04-14
EP0776200A4 (en) 2001-01-17

Similar Documents

Publication Publication Date Title
AU2502395A (en) Battery-actuated insecticide transpirator and method for transpirating insecticide
AU8693098A (en) Compositions and methods for treating diabetes
AU4139196A (en) Method and composition for antiviral therapy
AU8126198A (en) A skin care and protection composition and a method for preparation thereof
AU1589995A (en) Anti-withering composition for pines and anti-withering method
AU4012997A (en) Method and composition for incorporating radiation-absorbing agents into polymers
GB2298713B (en) Method and composition
AU3768095A (en) Herbicidal composition and method
AUPO976597A0 (en) Method and composition (I)
AU696892B2 (en) Maltitol composition and method for preparing it
AU7466998A (en) Method and material for inhibiting complement
AU3192295A (en) Substituted amine derivative and medicinal composition containing the same
AU3325095A (en) Composition and method for protection against drug dependency
AU6368394A (en) Polymer-polypeptide composition and method
AUPN137895A0 (en) Composition and method
AU7717894A (en) Method and composition for weight reduction
AU1578695A (en) Desogestrel-containing transdermal application agent
AU2110195A (en) Thiazolylpyrazolinones and their use for protecting technical materials
AU7352698A (en) Method and device for the protection of the human respiratory or gans
AUPO872197A0 (en) Explosives gasser composition and method
AU3466997A (en) Protection of database contents against use without permit
AU2461999A (en) Pharmaceutical composition and method for treating di-hydroxytestosterone dependent conditions
AU8002794A (en) Tree-protective coating agent and tree protection method
AU3631795A (en) Composition and method for immunotherapy
AU699468B2 (en) Herbicidal composition and method